ClinVar Miner

Submissions for variant NM_000038.6(APC):c.7055G>A (p.Ser2352Asn)

dbSNP: rs1554087958
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000507925 SCV000600144 uncertain significance not specified 2017-05-08 criteria provided, single submitter clinical testing
Invitae RCV002524428 SCV003465518 uncertain significance Familial adenomatous polyposis 1 2022-05-03 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 2352 of the APC protein (p.Ser2352Asn). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with APC-related conditions. ClinVar contains an entry for this variant (Variation ID: 438887). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV003159638 SCV003894834 uncertain significance Hereditary cancer-predisposing syndrome 2022-12-09 criteria provided, single submitter clinical testing The p.S2352N variant (also known as c.7055G>A), located in coding exon 15 of the APC gene, results from a G to A substitution at nucleotide position 7055. The serine at codon 2352 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.